Trials / Unknown
UnknownNCT04301674
Metabolomics in Occupational Asthma
Pilot Study of Metabolomics in Occupational Asthma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Oslo University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The project aims to increase the diagnostic accuracy in occupational asthma (OA), with emphasis on Irritant Induced Asthma (IIA). Currently, most patients are evaluated in occupational medicine by comparing the exposure and symptom characteristics with epidemiological data. Biological markers may be present in AA, but presently not in IIA. The majority of cases evaluated are considered as possible IIA, i.e. low-dose multiple exposures. VOC features will be analyzed with the Breath Biopsy® and TD-GS-MS (Owlstone Medical Ltd, UK).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Breath Biopsy | ReCIVA breath sampler (Owlstone Medical, Cambridge, UK) |
Timeline
- Start date
- 2021-10-15
- Primary completion
- 2022-12-31
- Completion
- 2023-06-01
- First posted
- 2020-03-10
- Last updated
- 2022-08-24
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04301674. Inclusion in this directory is not an endorsement.